Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMultimodality and Non-radioactive Molecular Imaging: Non-radioactive Molecular Imaging Agents - New Chemistry

Resonant cancer theranostics

Eric Silver, Anil Pradhan and Yan Yu
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1013;
Eric Silver
1Harvard-Smithsonian Center for Astrophysics, Cambridge, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil Pradhan
2The Ohio State University, Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Yu
3Thomas Jefferson University Medical School, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1013

Objectives By taking advantage of resonant absorption complexes in heavy-element-tagged nanoparticles or contrast agents delivered to disease sites, we can use tunable, narrow energy bands for both diagnosis and therapy to minimize radiation exposure to neighboring tissue.

Methods An electron beam ion trap (EBIT) developed for atomic and plasma physics investigations serves as the source of tunable, monochromatic X-rays for imaging and therapy. A cryogenic x-ray microcalorimeter developed for spectroscopic studies of laboratory and astrophysical plasmas makes the spectroscopic images. It is used to tune the X-ray emission from the EBIT plasma to the band of resonant absorption edges in the tagged nanoparticles. It can identify line emission with less than 20 counts per energy resolution element making the eventual dose for diagnostic imaging extremely low.

Results The EBIT and the microcalorimeter are described with emphasis on the hard X-ray energy range required by cancer theranostics. Fingerprints of heavy-element uptake in tagged malignant tissue will be presented.

Conclusions The electron beam ion trap is a smart x-ray source capable of generating monoenergetic resonant X-rays that maximally interact with the matching high-Z contrast agent or nanoparticles; the spectroscopic microcalorimeter is a “zero-background detector” and can discriminate resonant signatures with 10 times better resolution than any other X-ray spectrometer, thus providing very high sensitivity and specificity.

  • © 2009 by Society of Nuclear Medicine
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Resonant cancer theranostics
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Resonant cancer theranostics
Eric Silver, Anil Pradhan, Yan Yu
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1013;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Resonant cancer theranostics
Eric Silver, Anil Pradhan, Yan Yu
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1013;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Multimodality and Non-radioactive Molecular Imaging: Non-radioactive Molecular Imaging Agents - New Chemistry

  • Characterization of L-arabinose -induced gene expression in Salmonella typhimurium
  • Development of targeted medical imaging contrast agents: Assessment of cellular interactions using integrated optical nanoparticle labels
  • Selective localization of annexin V within depolarized skeletal muscle
Show more Multimodality and Non-radioactive Molecular Imaging: Non-radioactive Molecular Imaging Agents - New Chemistry

Non-radioactive MI Agents--New Chemistry Posters

  • Characterization of L-arabinose -induced gene expression in Salmonella typhimurium
  • Development of targeted medical imaging contrast agents: Assessment of cellular interactions using integrated optical nanoparticle labels
  • Selective localization of annexin V within depolarized skeletal muscle
Show more Non-radioactive MI Agents--New Chemistry Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire